COG Biospecimen Bank
COG 生物样本库
基本信息
- 批准号:8913447
- 负责人:
- 金额:$ 290.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-22 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdolescentAdverse effectsAffectBasic ScienceBiologicalCanadaCancer PatientChildChildhoodChildhood Cancer TreatmentClinicalClinical ResearchClinical TreatmentClinical TrialsClinical Trials Cooperative GroupCollectionCommunitiesConduct Clinical TrialsDataDatabasesDiagnosisEnrollmentEnsureFosteringGuidelinesHumanImprove AccessInformaticsInstitutionLaboratoriesMalignant - descriptorMalignant Childhood NeoplasmMalignant NeoplasmsMicroscopyMissionNational Clinical Trials NetworkNucleic AcidsPathologyPatientsPediatric HospitalsPediatric OncologyPediatric Oncology GroupPhasePlayProceduresProcessQuality ControlRandomizedResearchResearch InstituteResearch PersonnelResourcesRoleServicesSolutionsSpecimenStructureTestingTranslational ResearchTreatment outcomeTumor BankUnited StatesWorkanticancer researchbasebiobankcancer therapyimprovedphase II trialpopulation basedpublic health relevanceracial and ethnicsatisfactionsuccesstechnological innovationtooltreatment trialvirtual
项目摘要
DESCRIPTION (provided by applicant): The Children's Oncology Group (COG) is the pediatric clinical trials group of the National Clinical Trials Network (NCTN). Over 90% of United States and Canadian children and adolescents with cancer are treated at COG institutions with no racial, ethnic or geographic bias to registration, allowing for near-population-based clinical, translational and basic research. COG has established a strong track record of collecting and banking tumor and non-diseased biospecimens from patients enrolled in COG-sponsored clinical trials, most of which include randomized treatment questions. The COG Biospecimen Bank (COG BB), located within the Biopathology Center at Nationwide Children's Hospital, aims to provide high-quality pediatric and adolescent human malignant biospecimens to the research community. Annually, the COG BB receives and banks over 100,000 specimens from approximately 5,500 COG patients from over 225 COG institutions, and distributes approximately 10,000 specimens to approved investigators. The bank also offers services such as nucleic acid isolations, pathology review, virtual microscopy, clinical reference laboratory testing, and informatics initiatives. This proposal supports the collection, processing, and distribution of biospecimens from patient enrolled on COG Phase III and large Phase II trials (approximately 4,000 patients per year). The COG BB seeks to directly promote and support outstanding research in the diagnosis and treatment of pediatric cancer through centralized collection, quality control, storage, and distribution procedures. The COG BB will continue efforts to provide the latest biorepository based technological innovations and best practices, resulting in constant improvements in our operational capabilities, investigator access to biospecimens, investigator satisfaction, and the stewardship of these precious resources. Under proper regulatory guidelines and in association with the COG Statistical and Data Center, the COG BB will support translational aspects of cutting-edge research by ensuring appropriate tracking of biospecimens as well as linkages to existing demographic, clinical, biological, treatment, and outcome data. Finally the COG BB will provide investigators with a comprehensive database solution and dynamic informatics tools that facilitate pediatric cancer research, including the use of the Biospecimen IT Navigator and the NCTN Biospecimen front door services.
描述(由申请人提供):儿童肿瘤学组 (COG) 是国家临床试验网络 (NCTN) 的儿科临床试验组,超过 90% 的美国和加拿大癌症儿童和青少年在 COG 机构接受治疗。 COG 已建立了从注册患者收集和储存肿瘤和非疾病生物样本的良好记录。位于全国儿童医院生物病理学中心的 COG 生物样本库 (COG BB) 旨在为研究界提供高质量的儿科和青少年人类恶性生物样本。每年,COG BB 都会接收并储存来自超过 225 个 COG 机构的约 5,500 名 COG 患者的超过 100,000 份样本,并分发约该银行还向批准的研究人员提供 10,000 份样本,并提供核酸分离、病理学审查、虚拟显微镜检查、临床参考实验室测试和信息学计划等服务。该提案支持收集、处理和分发 COG 阶段患者的生物样本。 III 期和大型 II 期试验(每年约 4,000 名患者) COG BB 致力于通过集中收集、质量保证来直接促进和支持儿科癌症诊断和治疗方面的杰出研究。 COG BB 将继续努力提供基于生物样本库的最新技术创新和最佳实践,从而不断提高我们的运营能力、研究者对生物样本的获取、研究者的满意度以及这些宝贵资源的管理。在适当的监管指导下,并与 COG 统计和数据中心合作,COG BB 将通过确保对生物样本的适当跟踪以及与现有人口、临床、生物学、治疗和治疗的联系来支持尖端研究的转化。结果最后,COG BB 将为研究人员提供全面的数据库解决方案和动态信息学工具,以促进儿科癌症研究,包括使用 Biospecimen IT Navigator 和 NCTN Biospecimen 前门服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julie M Gastier-Foster其他文献
Julie M Gastier-Foster的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Julie M Gastier-Foster', 18)}}的其他基金
Improving the Accuracy of Diagnosis of Cancer in Children with HIV Infection
提高 HIV 感染儿童癌症诊断的准确性
- 批准号:
10427346 - 财政年份:2020
- 资助金额:
$ 290.84万 - 项目类别:
Improving the Accuracy of Diagnosis of Cancer in Children with HIV Infection
提高 HIV 感染儿童癌症诊断的准确性
- 批准号:
10657497 - 财政年份:2020
- 资助金额:
$ 290.84万 - 项目类别:
Improving the Accuracy of Diagnosis of Cancer in Children with HIV Infection
提高 HIV 感染儿童癌症诊断的准确性
- 批准号:
10223902 - 财政年份:2020
- 资助金额:
$ 290.84万 - 项目类别:
Improving the Accuracy of Diagnosis of Cancer in Children with HIV Infection
提高 HIV 感染儿童癌症诊断的准确性
- 批准号:
10084677 - 财政年份:
- 资助金额:
$ 290.84万 - 项目类别:
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 290.84万 - 项目类别:
Sensory Mechanisms of Cadmium-Induced Behavioral Disorders Across Generations
镉引起的几代人行为障碍的感觉机制
- 批准号:
10747559 - 财政年份:2023
- 资助金额:
$ 290.84万 - 项目类别:
Sensitive periods for prenatal alcohol exposure: a longitudinal study of DNA methylation and subsequent mental health
产前酒精暴露的敏感期:DNA 甲基化和随后心理健康的纵向研究
- 批准号:
10573715 - 财政年份:2023
- 资助金额:
$ 290.84万 - 项目类别:
Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling
酒精和电子烟通过嘌呤受体信号传导引起血脑和肺泡内皮屏障损伤
- 批准号:
10638221 - 财政年份:2023
- 资助金额:
$ 290.84万 - 项目类别:
Psychobiological Mechanisms Underlying the Association Between Early Life Stress and Depression Across Adolescence
早期生活压力与青春期抑郁之间关联的心理生物学机制
- 批准号:
10749429 - 财政年份:2023
- 资助金额:
$ 290.84万 - 项目类别: